LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$19.40
See how much of LYFAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 63 holdings · as of Mar 31, 2026
LYFAX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
FXFXX
First Am Treas Obli-XFinancials · Insurance
7.72%		7.7%-$3.04MFinancialsInsurance
2
GILD
Gilead SciencesHealth Care · Pharmaceuticals
7.18%		14.9%20,260$2.82MHealth CarePharmaceuticals
Share changes, sector and industry · Pro
3—Astrazeneca Plc
5.63%		20.5%11,232$2.22M
4—Nvaesrtex Pharmaceuticals Inc
5.60%		26.1%4,931$2.20M
5
IONS
Ionis Pharmaceuticals Inc
3.74%		29.9%19,587$1.47M
6
INSM
Insmed Inc
3.57%		33.4%8,583$1.40M
7
INCY
Incyte Corp.
3.41%		36.8%14,245$1.34M
8—Roivant Sciences Ltd. Common Shares
3.36%		40.2%47,667$1.32M
9—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.33%		43.5%1,794$1.31M
10
NBIX
Neurocrine Biosciences Inc
3.22%		46.8%9,607$1.27M
11
AXSM
Axsome Therapeutics, Inc.
2.77%		49.5%6,438$1.09M
12—Ascendis Pharma As Adr
2.63%		52.2%4,526$1.04M
13
APGE
Apogee Therapeutics Inc
2.43%		54.6%11,369$956.9K
14
PTGX
Protagonist Therapeutics Inc
2.42%		57.0%9,040$952.8K
15
AMGN
Amgen Inc.
2.08%		59.1%2,329$819.5K
16
RYTM
Rhythm Pharmaceuticals Inc
2.06%		61.1%9,297$808.6K
17
ABBV
AbbVie Inc.
1.96%		63.1%3,544$770.8K
18
BIIB
Biogen Inc.
1.79%		64.9%3,835$703.1K
19—Sanofi Sponsored Adr (1 Ads : 0.5 Ordinary)
1.76%		66.7%14,382$692.9K
20
JAZZ
Jazz Pharmaceuticals Plc.
1.71%		68.4%3,561$673.2K
21
CPARU
Catalyst Partners Acquisition Corp Ieu
1.47%		69.8%23,286$576.6K
22
ORKA
Oruka Therapeutics Inc Orka
1.44%		71.3%11,506$564.4K
23—Biontech Se Adr
1.27%		72.5%5,616$499.1K
24
KRYS
Krystal Biotech Inc
1.26%		73.8%1,918$495.5K
25
EWTX
Edgewise Therapeutics Inc.
1.25%		75.1%15,615$491.9K
26
NUVL
Nuvalent
1.21%		76.3%4,657$477.1K
27
AGIO
Agios Pharmaceuticals Inc
1.20%		77.5%13,971$472.6K
28—Newamsterdam Pharma Nv
1.19%		78.7%14,656$469.1K
29
MGTX
Meiragtx Holdings Plc
1.18%		79.8%53,694$465.0K
30
ALNY
Alnylam Pharmaceuticals Inc.
1.15%		81.0%1,370$453.3K
31
KYMR
Kymera Therapeutics Inc
1.13%		82.1%5,342$444.9K
32
PSNL
Personalis Inc
1.04%		83.2%64,032$407.9K
33
CLDX
Celldex Therapeutics Inc
1.02%		84.2%12,614$400.1K
34
NRIX
Nurix Therapeutics Inc
1.01%		85.2%25,571$396.4K
35—Abivax Sa Sponsored Adr (1 Ads : 1 Ordinary)
0.97%		86.2%3,424$381.3K
36
CYTK
Cytokinetics Inc
0.94%		87.1%5,616$370.1K
37
SYRE
Spyre Therapeutics Inc
0.85%		88.0%6,634$334.6K
38
HALO
Halozyme Therapeutics Inc
0.79%		88.7%4,794$309.8K
39
CGEM
Cullinan Therapeutics Inc
0.73%		89.5%20,135$286.1K
40
TRVI
Trevi Therapeutics Inc.
0.73%		90.2%23,970$286.0K
41
NTRA
Natera Inc
0.70%		90.9%1,370$274.0K
42—Xeris Pharmaceuticals Inc
0.68%		91.6%45,886$266.1K
43
IRON
Disc Medicine Inc
0.65%		92.2%3,972$254.0K
44
DSGN
Design Therapeutics Inc.
0.57%		92.8%21,231$225.9K
45
VCYT
Veracyte Inc
0.56%		93.4%6,838$220.3K
46—Rezolute Inc Pipe Deal Rzlt
0.55%		93.9%71,227$217.2K
47
TECX
Tectonic Therapeutic Inc Pipe
0.54%		94.5%6,849$211.7K
48
WVE
Wave Life Sciences Ltd
0.54%		95.0%29,175$211.5K
49
GLUE
Monte Rosa Therapeutics Inc
0.53%		95.5%12,566$206.7K
50
RAPP
Rapport Therapeutics, Inc.
0.51%		96.0%6,438$201.4K
More holdings · Pro
FundXLS Pro
See the other 13 holdings of LYFAX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

LYFAX Mutual Fund All Holdings

LYFAX holdings total 63 positions. The top 10 holdings account for 46.8% of the fund, led by First Am Treas Obli-X at 7.7%, Gilead Sciences at 7.2%, Astrazeneca Plc at 5.6%.

LYFAX portfolio concentration is moderate, with the top 10 representing 46.8% of total assets. The largest sector exposure is Health Care at 83.7%.

LYFAX sectors provide a detailed breakdown. LYFAX overlap shows how holdings compare to other funds in your portfolio.